Skip to Content

MYLAN MT 21 MYLAN MT 21 (Memantine Hydrochloride Extended-Release 21 mg)

Pill with imprint MYLAN MT 21 MYLAN MT 21 is Green & White, Capsule-shape and has been identified as Memantine Hydrochloride Extended-Release 21 mg. It is supplied by Mylan Pharmaceuticals Inc..

Memantine is used in the treatment of alzheimer's disease and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 21 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN MT 21 MYLAN MT 21

Memantine hydrochloride extended-release 21 mg MYLAN MT 21 MYLAN MT 21

Memantine Hydrochloride Extended-Release

Imprint
MYLAN MT 21 MYLAN MT 21
Strength
21 mg
Color
Green & White
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Miscellaneous central nervous system agents
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-5437
Inactive Ingredients
corn starch, sodium lauryl sulfate, sucrose, magnesium silicate, titanium dioxide, ferric oxide yellow, ammonia, ferrosoferric oxide, propylene glycol, shellac, FD&C Blue No. 2

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.